Macrocyclic and linear gadolinium based contrast agents for adults undergoing magnetic resonance imaging a review of safety
Contrast agents are widely used for magnetic resonance imaging (MRI) and angiography. These agents are administered intravenously and enhance the detail and clarity of images for more precise diagnoses. Although generally considered to be safe, the use of contrast agents may result in mild to severe...
| Main Authors: | , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2019, June 06, 2019
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | Contrast agents are widely used for magnetic resonance imaging (MRI) and angiography. These agents are administered intravenously and enhance the detail and clarity of images for more precise diagnoses. Although generally considered to be safe, the use of contrast agents may result in mild to severe adverse effects. The current Rapid Response report will seek to identify and synthesize the evidence around the risks and safety of macrocyclic and linear GBCAs for adults undergoing MRI. |
|---|---|
| Physical Description: | 1 PDF file (34 pages) illustration |